Quick Takeaways
- GCTK - Glucotrack, Inc. has 12 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 12 Insiders of Glucotrack, Inc.
- Symbol
- GCTK on Nasdaq
- Location
- Rutherford, NJ
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
There are no Buy or Sell transactions made by insiders since 06 Apr 2025
Glucotrack, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| John Ballantyne | Director, 10%+ Owner | $85,179,227 | Mixed | 16 Aug 2024 | ||
| John A. Ballantyne Revocable Living Trust dated 08/01/2017 | 10%+ Owner | $85,051,321 | Mixed | 30 Jul 2024 | ||
| Drew Sycoff | Director, 10%+ Owner | $3,718,585 | Filing P/S | 01 Jul 2024 | ||
| Robert Fischell | Director | $63,804 | Mixed | 24 Aug 2021 | ||
| Andrew K. Balo | Director | $22,850 | Mixed | 26 Mar 2025 | ||
| Luis Malave | Director | $19,762 | Mixed | 25 Mar 2025 | ||
| Allen Danzig | Director | $18,960 | Mixed | 04 Oct 2022 | ||
| Erin Catherine Carter | Director | $10,460 | Mixed | 25 Mar 2025 | ||
| Paul Goode | Chief Executive Officer, Director | $1,650 | Mixed | 25 Mar 2025 | ||
| Brendel Victoria Carr | Director | Mixed | 22 May 2025 | |||
| Peter C. Wulff | Chief Financial Officer | Mixed | 28 Jan 2025 | |||
| James S. Cardwell | Chief Financial Officer | Mixed | 11 Oct 2023 |
Recent Insider Transactions by Companies or Individuals for Glucotrack, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Andrew K. Balo | GCTK | Common Stock, par value $0.001 per share | Award | 37.7% | 1,285 | 4,692 | 03 Oct 2025 | Direct | ||
| Andrew K. Balo | GCTK | Stock option (right to buy) | Award | 4,055 | 4,055 | 03 Oct 2025 | Direct | |||
| Luis Malave | GCTK | Common Stock, par value $0.001 per share | Award | 12.9% | 463 | 4,058 | 03 Oct 2025 | Direct | ||
| Luis Malave | GCTK | Stock option (right to buy) | Award | 4,055 | 4,055 | 03 Oct 2025 | Direct | |||
| Erin Catherine Carter | GCTK | Common Stock, par value $0.001 per share | Award | 21.9% | 386 | 2,148 | 03 Oct 2025 | Direct | ||
| Erin Catherine Carter | GCTK | Stock option (right to buy) | Award | 4,055 | 4,055 | 03 Oct 2025 | Direct | |||
| Andrew K. Balo | GCTK | Common Stock, par value $0.001 per share | Award | 4442.7% | 3,332 | 3,407 | 11 Jul 2025 | Direct | ||
| Luis Malave | GCTK | Common Stock, par value $0.001 per share | Award | 50.1% | 1,200 | 3,595 | 11 Jul 2025 | Direct | ||
| Erin Catherine Carter | GCTK | Common Stock, par value $0.001 per share | Award | 131.2% | 1,000 | 1,762 | 11 Jul 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.